Efficacy of oxcarbazepine in reducing impulsivity in personality disorders;Eficacia antiimpulsiva de la oxcarbazepina en los trastornos de personalidad

Psiquiatria Biologica

Volumn 12, Issue 3, 2005, Pages 95-100

  Conejo Galindo, J ^a   Laita De Roda, P ^a   Monino Fernandez L ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Impulsivity; Oxcarbazepine; Personality disorder

Indexed keywords

OXCARBAZEPINE;

ADULT; AGGRESSIVENESS; ANXIETY; ARTICLE; BORDERLINE STATE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; EATING; FEMALE; HOSPITALIZATION; HUMAN; IMPULSIVENESS; IRRITABILITY; MALE; OPEN STUDY; PERSONALITY DISORDER; VISUAL ANALOG SCALE; VOMITING;

EID: 22544462265     PISSN: 11345934     EISSN: 15788962     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Roca Bennasar M, editor. Trastornos de personalidad. Barcelona: Ars Médica-Psiquiatría Editores; 2004. p. 244-7.
2. Peris Díaz MD, Ros Montalbán S. Tratamiento de los trastornos por impulsividad. Psiq Biol. 2002;9:29-34.
3. American Psychiatric Association. Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry. 2001;158 10 Suppl:1-52.
4. Moeller G, Barratt E, Dougherty D, Schmitz J, Swann A. Psychiatric aspects of impulsivity. Am J Psychiatry. 2001;158: 1783-93.
5. Plutchik R, Van Praag H. The nature of impulsivity: definitions, ontology, genetics and relation to aggression. En: Hollander E, Stein D, editor. Impulsivity and aggression. New York: Wiley; 1995. p. 7-24.
6. Faltus FJ. The positive effect of alprazolam in the treatment of three patients with borderline personality disorder. Am J Psychiatry. 1984;141:802-3.
7. Soloff PH, George A, Nathan RS. Progress on pharmacotherapy of borderline personality disorders: a double blind study amitriptyline, haloperidol and placebo. Arch Gen Psychiatry. 1986;43:691-7.
8. Hough DW. Low-dose olanzapine for self-mutilation behaviour in patients with borderline personality disorder. J Clin Psychiatry. 2001;62:296-7.
9. Griengl H, Sendera A, Dantendorfer K. Naltrexone as a treatment of self-injurious behaviour - a case report. Acta Psychiatr Scand. 2001;103:234.
10. Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M, et al. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol. 1995;15:23-9.
11. Hollander E. Managing aggressive behaviour in patients with obsessive-compulsive disorder and borderline personality disorder. J Clin Psychiatry. 1999;60 Suppl 15:38-44.
12. Pinto OC, Akiskal HS. Lamotrigine as a promising approach to borderline personality an open case series without concurrent DSM-IV mayor mood disorder. J Affect Disord. 1998; 51:333-43.
13. Townsend MH, Cambre KM, Barbee JG. Treatment of borderline personality disorder with mood instability with divalproex sodium: series of ten cases. J Clin Psychopharmacol. 2001;21:249-51.
14. Hollander E, Allen A, López RP, Bienstock CA, Grossman R, Siever LJ, et al. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. J Clin Psychiatry. 2001;62:119-203.
15. Gardner DL, Cowdry RW. Positive effects of carbamazepine on behavioural dyscontrol in borderline personality disorder. Am J Psychiatry. 1986;143:519-22.
16. Strzelec JS. A pilot study of oxcarbazepine in treatment of dysphoria with increased impulsivity [resumen de póster]. J Psychos Res. 2003;55:152.